← Back to All Stocks

60 Degrees Pharmaceuticals, Inc. (SXTP) Analysis

Generated on: 2025-06-22 14:28:59 UTC
All stock prices are delayed.
Use of this site does not constitute financial advice.
⚠️ VERY LOW FLOAT STOCK - 1,289,266 shares

Analysis Values

Current Price
$2.06
Predicted Price
$2.59
Expected Return
20.40%
Confidence Score
0.82
RSI (14)
33.55
MACD
-0.09
Volume
658,100
Float Shares
1,289,266
Reddit Posts
0
News Items
1
SEC Filings
0
Data Points
249

SXTP

60 Degrees Pharmaceuticals, Inc.
20.40%
Price: $2.06
Confidence: 0.82
News
Low Float
Last updated: 2025-06-22 14:28:58

Technical Analysis

RSI: 33.55
MACD: -0.09
Technical Analysis Graph

Risk Analysis

Volatility
157.24%
Max Drawdown
-91.02%
Beta
1.0
Risk Score
100

Social Sentiment

0
Social Sentiment Score (0-100)

Recent News

News thumbnail
TipRanks - 2025-06-04 12:55
60 Degrees Pharmaceuticals (SXTP) announced results of an insurance claims analysis related to babesiosis and chronic fatigue, as conducted by Komodo Health. Results showed approximately 25,000 Americans seek reimbursement for babesiosis-related medical costs each year, according to 60 Degrees Pharmaceuticals. In contrast, current estimates published by the Centers for Disease Control and Prevention show only 2,000 cases in 2020. Babesia infections last at least 12 months in 14 percent of patien

Reddit Discussions

No recent Reddit discussions found.

Recent SEC Filings

No recent SEC filings found.